Methanol → 4-[4-(4-Acetyl-1-piperazinyl)-1-piperidinyl]-2-(methyloxy)aniline

HRID 419373노트

반응식

HRID 419373 반응식
[BH4-].[Na+].[C:3]([N:6]1[CH2:11][CH2:10][N:9]([CH:12]2[CH2:17][CH2:16][N:15]([C:18]3[CH:23]=[CH:22][C:21]([N+:24]([O-])=O)=[C:20]([O:27][CH3:28])[CH:19]=3)[CH2:14][CH2:13]2)[CH2:8][CH2:7]1)(=[O:5])[CH3:4].CO>O.O.O.O.O.O.[Ni](Cl)Cl.C1COCC1>[C:3]([N:6]1[CH2:7][CH2:8][N:9]([CH:12]2[CH2:17][CH2:16][N:15]([C:18]3[CH:23]=[CH:22][C:21]([NH2:24])=[C:20]([O:27][CH3:28])[CH:19]=3)[CH2:14][CH2:13]2)[CH2:10][CH2:11]1)(=[O:5])[CH3:4]

참가 물질

6

반응물 3

HCID 887MethanolHCID 4311764Sodium borohydrideHCID 574161491-Acetyl-4-{1-[3-(methyloxy)-4-nitrophenyl]-4-piperidinyl}piperazine

생성물 1

HCID 574161484-[4-(4-Acetyl-1-piperazinyl)-1-piperidinyl]-2-(methyloxy)aniline수율 76%

시약·촉매·용매 2

HCID 11791229Dichloronickel;hexahydrate촉매HCID 8028Tetrahydrofuran용매

실험 절차

NaBH4 (0.190 g, 5.06 mmol) was added carefully in portions (exothermic) to a suspension of 1-acetyl-4-{1-[3-(methyloxy)-4-nitrophenyl]-4-piperidinyl}piperazine (0.52 g, 1.45 mmol), nickel(II)chloride hexahydrate (0.170 g, 0.72 mmol), MeOH (8 mL) and THF (4 mL) at 0° C. The ice bath was removed and the reaction mixture was stirred at rt overnight (˜16 h). The solvent was evaporated and the residue was suspended in DCM and filtered through celite. Flash chromatography afforded the title compound of step B (0.36 g, 76%). 1H NMR (400 MHz, DMSO-d6) δ 6.50-6.45 (m, 2H), 6.30-6.25 (m, 1H), 4.18 (bs, 2H), 3.71 (s, 3H), 3.45-3.36 (m, 6H), 2.45-2.38 (m, 3H), 2.31-2.23 (m, 1H), 1.96 (s, 3H), 1.82-1.74 (m, 2H), 1.58-1.44 (m, 2H).

후처리

  1. customThe ice bath was removed
  2. customThe solvent was evaporated
  3. filtrationfiltered through celite

출처 및 근거

ORD 기록
ord-cd5c246465c94359802318ff68453711
출처 데이터셋
uspto-grants-2012_01
특허 번호
US08093239B2

반응 노트

불러오는 중…